FDA Approves Tezspire for Chronic Rhinosinusitis With Nasal Polyps

TUESDAY, Oct. 28, 2025 (HealthDay News) -- The U.S. Food and Drug Administration approved Tezspire (tezepelumab-ekko; Amgen) for the add-on maintenance treatmen